96 related articles for article (PubMed ID: 6837085)
1. [Effects of metoprolol on the peripheral circulation in patients with peripheral vascular disease].
Diehm C; Mörl H; Schettler G
Z Kardiol; 1983 Jan; 72(1):44-7. PubMed ID: 6837085
[TBL] [Abstract][Full Text] [Related]
2. [Peripheral arterial vasoocclusive disease: no absolute contraindication to beta receptor blockers (author's transl)].
Diehm C; Comberg HU; Ey A; Mörl H; Schettler G
Dtsch Med Wochenschr; 1981 Oct; 106(43):1413-5. PubMed ID: 7285822
[TBL] [Abstract][Full Text] [Related]
3. Vasodilating effects of celiprolol in patients with peripheral obliterative arterial disease.
Diehm C
J Int Med Res; 1988; 16 Suppl 1():34A-38A. PubMed ID: 2975611
[TBL] [Abstract][Full Text] [Related]
4. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
[TBL] [Abstract][Full Text] [Related]
5. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
Arosio E; De Marchi S; Zannoni M; Prior M; Lechi A
Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710
[TBL] [Abstract][Full Text] [Related]
6. [Acute effects of metoprolol on blood pressure and heart rate. Value of the nitroglycerin test].
Chaignon M; Lucsko M; Aubert P; Guédon J
Arch Mal Coeur Vaiss; 1982 Sep; 75(9):963-9. PubMed ID: 6128964
[TBL] [Abstract][Full Text] [Related]
7. [Effect of digitalis on hemodynamics during rest in patients with arterial occlusive diseases, stage II, without cardiac insufficiency].
Brecht T; Bodem G; Schäfer E
Schweiz Med Wochenschr; 1982 Jan; 112(4):111-4. PubMed ID: 7063821
[TBL] [Abstract][Full Text] [Related]
8. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral vascular effects of metoprolol, pindolol and propranolol in hypertensive patients].
Joyal F; Bourque M; Kuchel O; Larochelle P
J Pharmacol; 1983; 14 Suppl 2():107-15. PubMed ID: 6138462
[TBL] [Abstract][Full Text] [Related]
10. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?
Wysokinski WE; Spittell PC; Pellikka PA; Miller WL; Seward JB
Int Angiol; 1998 Sep; 17(3):201-7. PubMed ID: 9821035
[TBL] [Abstract][Full Text] [Related]
11. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
[TBL] [Abstract][Full Text] [Related]
12. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
Allegra C; Pollari G; Carioti B; Sardina M
Int J Clin Pharmacol Ther; 1994 Dec; 32(12):646-51. PubMed ID: 7881702
[TBL] [Abstract][Full Text] [Related]
13. Abnormal cardiovascular response to exercise in patients with peripheral arterial disease: Implications for management.
Oka RK; Altman M; Giacomini JC; Szuba A; Cooke JP
J Vasc Nurs; 2005 Dec; 23(4):130-6; quiz 137-8. PubMed ID: 16326331
[TBL] [Abstract][Full Text] [Related]
14. Influence of metoprolol on hemodynamics and respiratory function in asthmatic patients.
Mue S; Sasaki T; Shibahara S; Takahashi M; Ohmi T; Yamauchi K; Suzuki S; Hida W; Takishima T
Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):346-50. PubMed ID: 489201
[TBL] [Abstract][Full Text] [Related]
15. Different effects of beta-1-adrenergic blocking agents with ISA or without ISA on peripheral blood flow.
Karnik R; Valentin A; Slany J
Angiology; 1987 Apr; 38(4):296-303. PubMed ID: 2883920
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
Schweiger H; Ortmeier CJ
Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
[TBL] [Abstract][Full Text] [Related]
17. Effects of hyperlipoproteinemias and their treatment on the peripheral circulation.
Zelis R; Mason DT; Braunwald E; Levy RI
J Clin Invest; 1970 May; 49(5):1007-15. PubMed ID: 5441536
[TBL] [Abstract][Full Text] [Related]
18. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
Seboldt H
Fortschr Med; 1980 Feb; 98(7):257-60. PubMed ID: 6767648
[TBL] [Abstract][Full Text] [Related]
19. Metoprolol in hypertension: an open evaluation.
Assaykeen TA; Michell G
Med J Aust; 1982 Jan; 1(2):73-7. PubMed ID: 7040924
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effect and tolerability of two fixed combination of metoprolol and hydrochlorothiazide followed by a long-term tolerance study with one combination.
Liedholm H; Ursing D
Ann Clin Res; 1981; 13 Suppl 30():45-53. PubMed ID: 7027893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
